Filter by
-
UMB Dataset
Substances nominated for inclusion on the 503B Bulks List: Betahistine HCl
- Alternate Title(s)
- Betahistine HCl: Summary Report
- Description
The University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI), in collaboration with the Food and Drug Administration (FDA), conducted research and outreach to solicit input from the public, including medical specialists, to better understand the use of certain bulk drug substances nominated for use in compounding by outsourcing facilities under section 503B of the...
- Subject
-
BetahistineDrug CompoundingLegislation, DrugUnited States. Food and Drug Administration
- Access Rights
- Unrestricted access